外科总监候选人凯西·米恩斯在参议院为她过去的迷幻药使用辩护，强调基于科学的政策和公共卫生。 Surgeon General nominee Casey Means defended her past psychedelic use before the Senate, stressing science-based policy and public health.

2026年2月25日，外科总监提名人凯西·米恩斯因其过去使用迷幻蘑菇而受到参议院审查，参议员苏珊·柯林斯质疑她在促进公共卫生方面的判断力和一致性。 Surgeon General nominee Casey Means faced Senate scrutiny on February 25, 2026, over her past use of psychedelic mushrooms, as Senator Susan Collins questioned her judgment and consistency in promoting public health. 这就意味着承认她的个人经历,但强调她的官方作用将以科学而不是个人信仰为指导。 Means acknowledged her personal experiences but stressed that her official role would be guided by science, not personal beliefs. 她引述了对心理健康的迷魂药进行有前途的研究,但申明她不建议公众使用这种药物。 While citing promising research on psychedelics for mental health, she affirmed she would not recommend such use to the public. 听证会强调了对被提名人的个人历史及其对公众信任的影响的关切,“方法”强调她致力于基于证据的政策并解决国家的毒品危机。 The hearing highlighted concerns about nominees’ personal histories and their impact on public trust, with Means emphasizing her commitment to evidence-based policy and addressing the nation’s drug crisis.